News

UC Berkeley and UCSF use AI-driven brain-computer interface to restore near real-time speech in paralysis patient.
In this Q&A, Rohit Nambisan, CEO of Lokavant, and Jonathan Crowther, head of predictive analytics, Pfizer, explore how AI is ...
The review found that while AI is making inroads in specific use cases, such as computer vision for medical imaging, ...
Jon Walsh, founder, chief scientific officer, Unlearn, explains how AI and digital twins are helping clinical trials become more efficient, patient-centric, and capable of supporting innovative study ...
Two new potential drugs have been designed by AI to kill drug-resistant bacteria, in a major Massachusetts Institute of ...
Recursion Pharmaceuticals (NASDAQ:RXRX) is a TechBio using its Recursion OS platform, which leverages AI to aid drug ...
Large language models (LLMs) are revolutionizing drug development. Researchers from China are exploring the applications of ...
Recent news reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and scientific research funding in jeopardy.
Discover key insights from Profound Medical's Q2 2025 earnings call, highlighting 70%-75% expected revenue growth, TULSA-AI launch, and CAPTAIN trial success.
HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of ...